Active Pharmaceutical Ingredient (Generic)

OCRELIZUMAB

🩺 IMMUNOSUPPRESSANTS 💊 1 Marketed Brands
Clinical Profile:

*Primary progressive Multiple sclerosis, Relapsing forms of multiple sclerosis:* BY IV INF: Adult: Initially 300 mg, then 300 mg after 2 weeks; maintenance 600 mg every 6 months; a minimum interval of 5 months should be maintained between each maintenance dose.

Marketed Brands Containing OCRELIZUMAB (1) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
OCREVUS 🏢 ROCHE
Inj 300 mg/10 ml 1 vial: Rs.510000.00
View Details →